Center for Drug Evaluation and Research

Type

Facility

Country

United States

US

ROR

00yf3tm42

not unique to one org

OpenAlex

I1333606569

the anchor

Documents

33

through any edge

Papers

33

authorship edges

Awards made

Named as funder

Papers

Documents in the 44B Library with Center for Drug Evaluation and Research on the authorship, newest first.

2026-07-14 · 4 authors here

Integrating human and artificial intelligence for robust postmarketing safety surveillance systems: reflections from the FDA Sentinel Innovation Center

2026-02-28 · 26 authors here

Statistical methods to harmonize electronic health record data across healthcare systems: case study and lessons learned

2026-02-01 · 16 authors here

Applications of artificial intelligence for real-world evidence generation: a protocol for a living scoping review

2025-12-12 · 20 authors here

Enhancing cause of death prediction: development and validation of machine learning models using multimodal data across multiple health-care sites

2025-11-27 · 16 authors here

Augmenting fact and date of death in electronic health records using internet media sources: a validation study from two large healthcare systems

2025-11-24 · 9 authors here

Leveraging Artificial Intelligence in Drug and Biological Product Development: An FDA and Clinical Trial Transformation Initiative Workshop Report

2025-10-24 · 5 authors here

Phenotyping using Structured Claims And Linked Electronic health records (PhenoSCALE): A semi-automated pipeline with an example of acute kidney injury

2025-10-01 · 6 authors here

Out‐of‐Distribution Detection as a Risk‐Control Strategy for Medical Classification Machine Learning Models

2025-09-04 · 16 authors here

A Systematic Process for Assessing Fitness-for-Purpose of Health Outcomes for Computable Phenotyping with Electronic Health Record Data

2025-06-24 · 22 authors here

Enhancing Cause of Death Prediction: Development and Validation of ML Models Using Multimodal Data Across Multiple Healthcare Sites

2025-02-28 · 9 authors here

AI-powered topic modeling: comparing LDA and BERTopic in analyzing opioid-related cardiovascular risks in women

2025-01-01 · 6 authors here

Public feedback to FDA on regulatory considerations for AI in drug manufacturing

2025-01-01 · 7 authors here

Semantic Search of FDA Guidance Documents Using Generative AI

2024-11-01 · 14 authors here

Automated Extraction of Mortality Information from Publicly Available Sources Using Language Models

2024-11-01 · 17 authors here

Artificial Intelligence in Cardiovascular Clinical Trials

2024-10-08 · 17 authors here

Scalable incident detection via natural language processing and probabilistic language models

2024-09-01 · 1 authors here

S25-04 Into the SEND data-verse: with great virtual power comes great regulatory responsibility

2024-07-25 · 8 authors here

Harnessing large language models’ zero-shot and few-shot learning capabilities for regulatory research

2024-07-17 · 17 authors here

Improving Collection and Analysis of Overall Survival Data

2024-05-14 · 8 authors here

A general framework for developing computable clinical phenotype algorithms

2024-05-09 · 8 authors here

Two-stage fine-tuning with ChatGPT data augmentation for learning class-imbalanced data

2024-04-01 · 7 authors here

A framework enabling LLMs into regulatory environment for transparency and trustworthiness and its application to drug labeling document

2024-03-20 · 4 authors here

Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine

2023-12-18 · 18 authors here

Data-driven automated classification algorithms for acute health conditions: applying PheNorm to COVID-19 disease

2023-12-16 · 15 authors here

Current Status and Future Directions: The Application of Artificial Intelligence/Machine Learning for Precision Medicine

Showing 25 of 33 on record.

Funding

Read from the funding tables, never from the document count — that count includes authorship, so it ranks institutions, not funders.

Who funds this work

Funders named on the papers above. The record holds no recipient field, so this is reached through the documents themselves — and the two columns are two different claims, kept apart.

© 2026 NYSGPTLast Updated: August 5, 2026